Option chain shows key data for Curis's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Curis.

Curis (NASDAQ:CRIS) Stock, Option Chain

Curis

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

News

Penny Stocks

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

CRIS

RVMD

As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Top 3 Health Care Stocks That May Collapse In Q2

Price Target

Analyst Ratings

CYBR

LBTYA

NOTV

PCTY

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

CyberArk Software To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Friday

Small Cap

Intraday Update

Movers

ANVS

DWAC

ENSC

EVAX

EVER

GETR

GPAK

GYRE

HRTX

KURA

LCID

MMAT

NFLX

NYXH

PRPL

RDHL

RVSN

SAVE

SBEV

SIDU

SMMT

SPRC

SRAD

SWIN

VSME

Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes.

BlackBerry shares tumbled 17.2% to $2.9387 on Wednesday.

Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Curis Inc

CRISPR Therapeutics AG

CRISM THERAPEUTICS CORP by CRISM THERAPEUTICS CORP

Crism Therapeutics Corp

Press Releases

Curis to Present at Upcoming Healthcare Conferences in September

Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer

Offerings

Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement

Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024

Earnings

Curis Provides Third Quarter 2024 Business Update

Curis Announces Additional Data from TakeAim Leukemia Study

Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025

Curis Provides Fourth Quarter 2024 Business Update

Curis to Present at Upcoming Healthcare Conference in April

Abpro Hldgs

ABVC BioPharma

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

BioVie

Bolt Biotherapeutics, Inc. - Common Stock

Bolt Biotherapeutics

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Elevation Oncology

Equillium

GlycoMimetics

IN8bio

Kala Bio

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Leap Therapeutics

Lisata Therapeutics

Moleculin Biotech

MEI Pharma

Nanoviricides

Passage Bio

BiomX

Portage Biotech

Q32 Bio

Tenax Therapeutics

Unity Biotechnology

HC Wainwright & Co.

Truist Securities

Cantor Fitzgerald

Comments

Curis

Curis (CRIS) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell